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Mr. RW is a 27-year-old man referred from a district
hospital following a motor vehicle crash. He was
intubated and ventilated with 100% oxygen. Bilat-
eral intercostal drains were inserted for respiratory
distress and poor saturation. Oxygen saturation
remained between 84 and 90% during transfer. On
arrival: the trachea was central, poor air entry
bilaterally was detected and bilateral functioning
chest drains were in-situ. He had a sinus tachycardia
of 110/min, a blood pressure of 80/45 mmHg and
cool peripheries. The Glasgow Coma Scale score was
6T. The abdomen was scaphoid. He was moving all
limbs and there were no open wounds or obvious
bony injuries. Initial chest radiograph showed more
than 80% diffuse opacity in both lung fields (Fig. 1).
Arterial blood gas results revealed a pO2 of 8.0 kPa
and pCO2 of 6.4 kPa on 100% oxygen. Cervical spine
and pelvis plain radiographs were normal, as well as
a CAT scan of the brain and abdomen. Inotropic
support was commenced.
He was admitted to the surgical intensive care
unit. Numerous recruitment manoeuvres were per-
formed which improved ventilation and saturation.* Corresponding author. Tel.: +27 21 4044117;
fax: +27 21 4044115.
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97% on a FiO2 of 40% and inotropes were weaned.
Over next 48 h, there was a dramatic radio-
graphic improvement with clearing of the bilateral
diffuse opacities (Fig. 2). A persistent medial pneu-
mothorax was noted on the left. There was no
evidence of blunt myocardial injury. His stay in
ICU was protracted by a Pseudomonas and Acineto-
bacter nosocomial pneumonia.
The rapid clearing of the chest radiograph was
not consistent with severe lung contusion or aspira-
tion pneumonia with acute respiratory distress syn-
drome (ARDS) and the diagnosis of reexpansion
pulmonary oedema (RPO) was considered.Discussion
Reexpansion pulmonary oedema occurs when a col-
lapsed lung rapidly expands after the evacuation of
pleural air or fluid. RPO is relatively uncommon. A
total of 47 cases of RPO has been reported between
1958 and 1987,2 83% were from the reexpansion of a
chronically collapsed lung; 83% were on the affected
side; 6.7% were bilateral and a few occurred on the
contralateral side. The incidence of RPO in patients
treated for spontaneous pneumothorax is about
14%.3
Predisposing factors include:se.
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Figure 1 Chest radiograph revealing bilateral diffuse opacity.
Figure 2 Chest radiograph showing rapid clearance of opacity.
Bilateral reexpansion pulmonary oedema 2051. Age: there is an increased incidence in patients
aged 20—39 years with spontaneous pneu-
mothorax.32. Duration of pneumothorax: with spontaneous
pneumothorax, the average duration before
presentation and decompression resulting in
RPO was 14 days with a minimum of 3 days.33. Severity or size of pneumothorax: no patient
with a pneumothorax of less than 30% developed
RPO. The size of the pneumothorax seems to be
of more significance than the duration before
presentation.34. Method of reexpansion: Rapid reexpansion and
low pressure suction increases the risk of RPO.4
RPO can however occur without suction and the
risk seems to relate to the interaction of the factors
of size, duration and rate of expansion.
Symptoms and signs include severe coughing,
tachypnoea and tachycardia, with increasing
hypoxia, which does not respond to oxygen therapy.7
Hypotension may occur if there are large third space
fluid losses into the lungs.1 Symptoms are often
immediate with 64% developing within the first hour
and all are symptomatic within 24 h. Symptoms
usually resolve in 24—72 h.
The pathophysiology of RPO is incompletely
understood. The end point results from increased
capillary permeability and fluid leakage into alveo-
lar and interstitial spaces. There is mechanical
injury to the alveolar-capillary membrane when
the lung expands. Blood flow returns rapidly to
the expanded lung resulting in a reperfusion injury.
Once microvascular damage is established, an acute
inflammatory response is initiated resulting in nitric
oxide imbalances at a cellular level, neutrophil
aggregation and degranulation.8 Inflammatory med-
iators, such as interleukin 8 and monocyte chemo-
attractant protein have been found in the affected
and to a lesser extent the unaffected lung.5,6 There
are therefore similarities with the pathological
mechanism premised for the development of ARDS.
The management is primarily supportive
with oxygenation and there should be a low
threshold for mechanical ventilation. Respiratory
support should be accompanied by diuresis andcardiovascular support. Prostaglandins, such as mis-
oprostil and ibuprofen or indocid may be used early
on in therapy. The aim here is to prevent further cell
damage and diminish the inflammatory cascade.9
Patients should be positioned in lateral decubitus
with the affected side up. Intercostal drain with
underwater seal should be used to encourage reex-
pansion and suction can be applied once the lung is
almost completely expanded.
There is no clinical evidence to clearly support
any method of prevention. In the management of a
large (>30%) pneumothorax, The American College
of Chest Physicians recommends the use of a small
bore catheter (16F—22F) and an underwater seal
without suction. If the lung does not fully expand,
suction can then be applied.
Reexpansion pulmonary oedema usually resolves
within 24—72 h. However, current evidence suggests
a mortality of approximately 20%.9 This high
mortality in a relatively rare condition makes pre-
vention, clinical awareness and early diagnosis
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